Lamellar Biomedical develops novel healthcare products based on the mimicry or modification of the lamellar body secretory system.
Lamellar Biomedical Ltd was established in June 2007 when the founding Directors of the Company, recognising the considerable therapeutic potential of Lamellasomes™, acquired the intellectual property rights to the technology.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 8, 2017 | Series C | £5.75M | 1 | Invesco | — | Detail |
Jul 24, 2015 | Series Unknown | £2.33M | 2 | — | — | Detail |
Jan 7, 2013 | Series A | £3.30M | 2 | Invesco | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Invesco | Yes | Series C |
Barwell Plc | — | Series Unknown |